We found that treatment with ANGPTL3-CM in liver cancer cell lines (Mahlavu, Huh7, and HepG2) led to reduced cell migration (Fig. 3D), indicating that both intracellular and extracellular ANGPTL3 suppress cell motility. Here, ANGPTL3 is linked to liver cancer.